Navigation Links
Codon Bias-Adjusted BL21 Derivatives for Protein Expression


High-level expression of difficult heterologous proteins

Carsten-Peter Carstens Anna Waesche
Stratagene

Stratagene has created variants of the Epicurian Coli BL21-Gold cells * called the BL21-CodonPlus -RIL series** of strains, which contain extra copies of the E. coli argU, ileY, and leuW tRNA genes. This modification allows for a high-level expression of proteins that are difficult to express in conventional E. coli hosts due to the codon bias of the gene of interest. The BL21-CodonPlus-RIL strains can eliminate the need to move the gene of interest into eukaryotic expression systems.

BL21-Gold(DE3) cells are the strain of choice for high-level production of heterologous proteins expressed from the T7-promoter. These strains have been engineered to contain an inducible T7-RNA polymerase. They are also EndA- to allow high-quality miniprep DNA preparation.1 BL21 competent cells are derivatives of E. coliB and lack the Lon protease and the ompT protease genes that may cause instability and degradation of the recombinant protein.

Table 1
Rarest Codons (from E. coli) Preferred by Selected Organisms

Codon frequencies are expressed as codons used per 1000 codons encountered. A complete compilation of codon usage of the sequences placed in the gene bank database can be found at http://www.dna.affrc.go.jp/~nakamura/codon.html Codon frequencies of more than 15 codons/1000 codons are shown in bold to help identify a codon bias that may cause problems for high-level expression in E. coli. The arginine codons AGG and AGA are recognized by the same tRNA (product of the argU gene) and should therefore be combined. However, regardless of the origin of the coding region of interest, each gene should be assessed individually. Even E. coli contains genes with poor codon usage for efficient translation.

AGG arginine

AGA arginine

CGA arginine

CUA leucine

AUA isoleucine

CCC proline

Escherichia coli

1.4

2.1

3.1

3.2

4.1

4.3

Homo sapiens

11.0

11.3

6.1

6.5

6.9

20.3

Drosophila melanogaster

4.7

5.7

7.6

7.2

8.3

18.6

Caenorhabditis elegans

3.8

15.6

11.5

7.9

9.8

4.3

Saccharomyces cerevisiae

9.3

21.3

3.0

13.4

17.8

6.8

Plasmodium falciparium

4.1

20.2

0.5

15.2

33.2

8.5

Clostridium pasteurianum

2.4

32.8

0.8

6.0

52.5

1.0

Pyrococcus horikoshii

30.3

20.4

1.0

18.0

44.9

10.1

Thermus aquaticus

13.7

1.4

1.4

3.2

2.0

43.0

Arabidopsis thaliana

10.9

18.4

6.0

9.8

12.6

5.2

Although strains of the BL21-Gold series are the most convenient and effective bacterial hosts for protein production presently available, expression of heterologous recombinant genes in E. coli is frequently limited when the codon usage in the recombinant gene differs from host cells (Table 1). Forced high-level expression of a gene, with codons that are rarely used by E. coli, results in depletion of the internal tRNA pools.2 As a consequence, translation of the recombinant RNA species is delayed, leading to its enhanced degradation. The result of rare codon usage is most frequently seen as ineffective to nondetectable production of the target protein and the formation of aborted translation products that have the appearance of proteolytic degradation. In addition, rare codons may also affect the quality of the produced proteins by inducing translation frameshifts, codon skipping, and frequent misincorporation of amino acids. Misincorporation rates of up to 40% have been reported at specific rare arginine codons.3

The deleterious effects of rarely used codons have been most thoroughly documented for the arginine codons AGA and AGG, which are the rarest codons in E. coli. However, codons for isoleucine (AUA), leucine (CUA), and proline (CCC) have also been demonstrated to affect protein production and quality in E. coli hosts. The expression of affected recombinant genes can be salvaged either by synonymous replacement of the rare codons with more frequently used codons using site-directed mutagenesis or by supplementing the host with extra copies of the cognate tRNA genes.

Now, Stratagene has generated BL21-CodonPlus-RIL chemically competent cells that carry extra copies of the argU, ileY, and leuW tRNA genes. The tRNAs encoded by these genes recognize the AGA/AGG, AUA, and CUA codons, respectively. To demonstrate their ability to facilitate the expression of heterologous recombinant genes that are only marginally expressed in conventional BL21 strains, BL21-CodonPlus(DE3)-RIL cells were transformed with vectors expressing genes fromhuman, yeast, and archaeal origins using the T7 RNA polymerase responsive promoter. IPTG-induced expression of all recombinant genes greatly increased in the BL21-CodonPlus(DE3)-RIL cells, compared to their expression in BL21-Gold(DE3) (Figure 1).

Fig.1

Expression of Difficult Proteins

To demonstrate the efficiency of BL21-CodonPlus-RIL cells to facilitate protein production in genes affected by poor codon usage, we compared the expression of a codon-adjusted form of the human cardiac troponin-T gene in conventional BL21-GoldDE3 cells (Figure 1,hcTnT-mut) with expression of the wild-type (hcTnT-wt) form in BL21-CodonPlus(DE3)-RIL cells. The expression of hcTnT in E. coli was previously shown to be solely restricted by the presence of two rare arginine codon pairs.4 This was demonstrated by synonymous replacement of the rare arginine codon pairs with frequently used arginine codons (hcTnT-mut), which results in efficient production of hcTnT-mut in E. coli. In Figure 1, BL21-CodonPlus(DE3)-RIL cells express hcTnT-wt at the same level observed for the codon-adjusted hcTnT-mut in conventional BL21-Gold(DE3) cells. Hence, using BL21-CodonPlus(DE3)-RIL strains are as efficient as employing the conventional and time-consuming method of synonymous replacement of rare codons to achieve high-level expression of codon-usage restricted recombinant genes.

Fig.2

The simultaneous expression of several rare tRNA genes in BL21-CodonPlus(DE3)-RIL not only provides a generic host for expression of recombinant genes affected by a range of rare codons but is also necessary for some recombinant genes to achieve a high level of expression. In Figure 2, using an archaeal gene as an example, efficient production of this recombinant gene in E. coli hosts requires the simultaneous presence of functional extra copies of both argU and ileY tRNA genes. Variants of the BL21-CodonPlus(DE3)-RIL strains lacking either the argU or ileY gene, while retaining the other tRNA genes, failed to produce the target gene at the same level as observed in the BL21-CodonPlus(DE3)-RIL strain. The functional expression argU and ileY genes in each of thevariant strains were confirmed using expression constructs, which are dependent only on either argU function (hcTnT) or ileY function (3xi) for efficient expression. The artificial construct 3xi is derived from a well-expressed recombinant gene by insertion of three AUA codons (ile) at the N-terminus.

The host cells did not suffer any obvious deleterious effects from the extra copies of tRNA genes. Growth rates and transformation efficiencies were comparable to the parental BL21-Gold cells. When comparing BL21-CodonPlus(DE3)-RIL cells with BL21-Gold(DE3) cells, production of recombinant genes like Jun-N-terminal kinase (JNK) or l-phosphatase, that are well expressed in conventional BL21 cells, were indistinguishable between the two strains (Figure 1).

Conclusions

Stratagenes new BL21-CodonPlus series of competent cells allows high-level expression of recombinant genes that are restricted in their expression in conventional E. coli due to codon usage bias. Many proteins can be expressed in BL21-CodonPlus-RIL cells instead of moving into a different expression system.

Acknowledgements

The authors thank Alan Greener, Connie Hansen, and Xiuyuan Hu.

REFERENCES
  1. Jerpseth, M., et al. (1998) Strategies 11: 3-4.

  2. Kane, J.F. (1995) Curr. Opin. Biotechnol. 6: 494-500.

  3. Forman, M.D., et al. (1998) Protein Sci. 7: 500-503.

  4. Hu, X., et al. (1996) Protein Expr. Purif. 7: 289-293.

* Patent pending
** Patents pending


'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. High-Level Expression of Peanut Allergens Affected by Rare Codon Usage
2. New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes
3. High-efficiency Derivatives of the BL21 Series for Protein Expression
4. A New C-Terminal GST Vector for Protein Production in S. pombe
5. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
6. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
7. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
8. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
9. Optimized Imaging of Protein Gels Stained with Coomassie Brilliant Blue Dye
10. High-Level Protein Expression, One-Column Purification, and FLAG Epitope Tagging in E. coli
11. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Codon Bias Adjusted Derivatives for Protein Expression

(Date:7/29/2015)... , July 30, 2015 According ... Market - Growth, Trends & Forecasts (2015-2020), , published by ... US$ 30.25 billion by the end of 2020, with ... accounting for more than 40% of the global market size. ... at a CAGR of 13.7% during the period of (2015-2020). ...
(Date:7/29/2015)... - BioAmber Inc. (NYSE: BIOA ) today announced that ... has resigned.  The Company has hired Andrew Ashworth ... December 2014, as full time interim CFO and has ... Andy Ashworth began his employment today, to ... Andy was the Company,s CFO from September 2011 to ...
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., the ... their 2nd generation cell therapy POD® design. The 2nd generation portfolio not only ... a new POD® design. , “G-CON first offered our miniPOD CT product ...
(Date:7/29/2015)... 2015  AmnioChor Inc., an early stage biotech startup ... to announce that the Musculoskeletal Transplant Foundation of ... in their seed round of development of the proprietary ... AmnioChor,s technology allows cryopreservation of the ... cells living within those tissues. Amnion is a well-established ...
Breaking Biology Technology:Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2
... - The Madison-based Imago Scientific Instruments has ... State University's College of Engineering for use in ... Analysis. , ,The lab will be the primary research ... led by Balaji Narasimhan, an associate professor of chemical ...
... Wisconsin's economy evolves, regional collaboration is key to the ... companies that do business here. , ,Our state boasts ... capital, but alone we lack the critical mass needed ... East and West Coasts - for the resources so ...
... CDW Corp. , the Illinois-based technology provider that recently ... top salesman to handle Berbee's transition into the company. ... sales Steven Schuldt in charge of merging Berbee, a ... in Vernon Hills, Ill., acquired the privately-held Berbee on ...
Cached Biology Technology:Regional collaboration is key to state's future 2Regional collaboration is key to state's future 3
(Date:7/8/2015)... NEW YORK , July 8, 2015 /PRNewswire/ ... today announced BD & Guidepoint Mentor, a ... access to Guidepoint,s expert network services. ... cutting-edge technologies to improve healthcare delivery and outcomes and, ... each start-up entrepreneur will be able to directly engage ...
(Date:7/8/2015)... SPRINGS, Florida , July 8, 2015 ... constantly evolving as this summer,s must have products such as ... in demand as popularity for biometrics based devices continues to ... are NXT-ID, Inc. (NASDAQ: NXTD ), Google Inc. (NASDAQ: ... Inc. (NYSE: FIT ), GoPro, Inc. (NASDAQ: GPRO ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... Special Surgery researchers have found that statins may be ... from pregnancy complications caused by antiphospholipid syndrome (APS), according ... the body produces antibodies directed at phospholipids, the main ... study published in the October issue of the ...
... from the Herman B Wells Center for Pediatric Research at ... family of blood proteins that they hope holds a ... and adults. Their findings may one day help ... and other cancers of the blood. The researchers, led ...
... have created nanowire sensors coupled with simple microprocessor electronics ... used for point-of-care (POC) disease detection, according to a ... use activation of immune cells by highly specific antigens ... as the detector. When T cells are activated, they ...
Cached Biology News:Statins may prevent miscarriages 2Statins may prevent miscarriages 3On the trail of a targeted therapy for blood cancers 2Sensitive nanowire disease detectors made by Yale scientists 2
... Service, We deliversoluble protein or No ... yields the best soluble protein results , ... clone submitted , Powerful results on your ... Solubility Optimization Service (SOS) uses proprietary tools ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... ProteinChip beta-amyloid Multipeptide Kit, designed for ... detecting a variety of amyloid peptides ... before. - Clinical neuroscience proteomics applications ... treatment - Correlate beta-amyloid peptide levels ...
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
Biology Products: